Medical - Distribution
Compare Stocks
5 / 10Stock Comparison
WGRX vs HSIC vs OMI vs HCSG vs MCK
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Distribution
Medical - Distribution
Medical - Care Facilities
Medical - Distribution
WGRX vs HSIC vs OMI vs HCSG vs MCK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Distribution | Medical - Distribution | Medical - Distribution | Medical - Care Facilities | Medical - Distribution |
| Market Cap | $8M | $8.09B | $171M | $1.60B | $92.15B |
| Revenue (TTM) | $6M | $13.18B | $2.76B | $1.84B | $403.43B |
| Net Income (TTM) | $-73M | $398M | $-1.10B | $59M | $4.76B |
| Gross Margin | 4.1% | 29.1% | — | 13.3% | 3.6% |
| Operating Margin | -12.1% | 5.8% | 1.0% | 3.0% | 1.5% |
| Forward P/E | — | 13.3x | 2.3x | 20.8x | 19.3x |
| Total Debt | $25M | $3.69B | $320M | $25M | $7.39B |
| Cash & Equiv. | $1M | $156M | $282M | $161M | $5.69B |
WGRX vs HSIC vs OMI vs HCSG vs MCK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 25 | May 26 | Return |
|---|---|---|---|
| Wellgistics Health,… (WGRX) | 100 | 3.3 | -96.7% |
| Henry Schein, Inc. (HSIC) | 100 | 97.7 | -2.3% |
| Owens & Minor, Inc. (OMI) | 100 | 23.1 | -76.9% |
| Healthcare Services… (HCSG) | 100 | 212.5 | +112.5% |
| McKesson Corporation (MCK) | 100 | 117.5 | +17.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: WGRX vs HSIC vs OMI vs HCSG vs MCK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
WGRX lags the leaders in this set but could rank higher in a more targeted comparison.
HSIC is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.73, Low D/E 76.9%, current ratio 1.38x
OMI ranks third and is worth considering specifically for value.
- Lower P/E (2.3x vs 13.3x)
HCSG carries the broadest edge in this set and is the clearest fit for quality and momentum.
- 3.2% margin vs WGRX's -13.0%
- +55.8% vs WGRX's -98.0%
- 7.3% ROA vs WGRX's -138.4%, ROIC 9.0% vs -32.2%
MCK is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 17 yrs, beta 0.04, yield 0.4%
- Rev growth 16.2%, EPS growth 14.9%, 3Y rev CAGR 10.8%
- 348.1% 10Y total return vs HSIC's 5.3%
- PEG 0.49 vs HSIC's 4.21
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.2% revenue growth vs WGRX's -91.8% | |
| Value | Lower P/E (2.3x vs 13.3x) | |
| Quality / Margins | 3.2% margin vs WGRX's -13.0% | |
| Stability / Safety | Beta 0.04 vs OMI's 1.44 | |
| Dividends | 0.4% yield; 17-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +55.8% vs WGRX's -98.0% | |
| Efficiency (ROA) | 7.3% ROA vs WGRX's -138.4%, ROIC 9.0% vs -32.2% |
WGRX vs HSIC vs OMI vs HCSG vs MCK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
WGRX vs HSIC vs OMI vs HCSG vs MCK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HCSG leads in 2 of 6 categories
HSIC leads 1 • OMI leads 1 • MCK leads 1 • WGRX leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HSIC leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MCK is the larger business by revenue, generating $403.4B annually — 71797.5x WGRX's $6M. HCSG is the more profitable business, keeping 3.2% of every revenue dollar as net income compared to WGRX's -13.0%. On growth, HSIC holds the edge at +7.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $6M | $13.2B | $2.8B | $1.8B | $403.4B |
| EBITDAEarnings before interest/tax | -$65M | $1.1B | $277M | $72M | $6.8B |
| Net IncomeAfter-tax profit | -$73M | $398M | -$1.1B | $59M | $4.8B |
| Free Cash FlowCash after capex | -$7M | $561M | -$353M | $139M | $6.0B |
| Gross MarginGross profit ÷ Revenue | +4.1% | +29.1% | — | +13.3% | +3.6% |
| Operating MarginEBIT ÷ Revenue | -12.1% | +5.8% | +1.0% | +3.0% | +1.5% |
| Net MarginNet income ÷ Revenue | -13.0% | +3.0% | -39.8% | +3.2% | +1.2% |
| FCF MarginFCF ÷ Revenue | -130.5% | +4.3% | -12.8% | +7.6% | +1.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -80.9% | +7.7% | -146.3% | +6.6% | +6.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -11.8% | +14.9% | +4.5% | +175.0% | +37.0% |
Valuation Metrics
OMI leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 21.6x trailing earnings, HSIC trades at a 26% valuation discount to MCK's 29.2x P/E. Adjusting for growth (PEG ratio), MCK offers better value at 0.75x vs HSIC's 6.84x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $8M | $8.1B | $171M | $1.6B | $92.1B |
| Enterprise ValueMkt cap + debt − cash | $32M | $11.6B | $209M | $1.5B | $93.8B |
| Trailing P/EPrice ÷ TTM EPS | -0.68x | 21.56x | -0.16x | 27.54x | 29.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 13.26x | 2.31x | 20.83x | 19.28x |
| PEG RatioP/E ÷ EPS growth rate | — | 6.84x | — | — | 0.75x |
| EV / EBITDAEnterprise value multiple | — | 10.87x | 1.70x | 22.38x | 18.74x |
| Price / SalesMarket cap ÷ Revenue | 0.44x | 0.61x | 0.06x | 0.87x | 0.26x |
| Price / BookPrice ÷ Book value/share | 0.68x | 1.79x | — | 3.19x | — |
| Price / FCFMarket cap ÷ FCF | — | 14.12x | — | 11.49x | 17.63x |
Profitability & Efficiency
HCSG leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MCK delivers a 3.0% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-21 for OMI. HCSG carries lower financial leverage with a 0.05x debt-to-equity ratio, signaling a more conservative balance sheet compared to WGRX's 3.73x. On the Piotroski fundamental quality scale (0–9), HCSG scores 7/9 vs OMI's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -10.8% | +8.2% | -21.1% | +11.8% | +3.0% |
| ROA (TTM)Return on assets | -138.4% | +3.6% | -44.9% | +7.3% | +5.7% |
| ROICReturn on invested capital | -32.2% | +7.1% | +1.8% | +9.0% | +5.4% |
| ROCEReturn on capital employed | -73.4% | +9.8% | +1.3% | +7.7% | +30.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 2 | 7 | 6 |
| Debt / EquityFinancial leverage | 3.73x | 0.77x | — | 0.05x | — |
| Net DebtTotal debt minus cash | $24M | $3.5B | $38M | -$136M | $1.7B |
| Cash & Equiv.Liquid assets | $1M | $156M | $282M | $161M | $5.7B |
| Total DebtShort + long-term debt | $25M | $3.7B | $320M | $25M | $7.4B |
| Interest CoverageEBIT ÷ Interest expense | -10.95x | 4.59x | -0.12x | 33.02x | 33.79x |
Total Returns (Dividends Reinvested)
MCK leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MCK five years ago would be worth $38,689 today (with dividends reinvested), compared to $232 for WGRX. Over the past 12 months, HCSG leads with a +55.8% total return vs WGRX's -98.0%. The 3-year compound annual growth rate (CAGR) favors MCK at 27.3% vs WGRX's -71.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -79.7% | -8.2% | -3.4% | +28.6% | -8.5% |
| 1-Year ReturnPast 12 months | -98.0% | +5.9% | -71.1% | +55.8% | +4.6% |
| 3-Year ReturnCumulative with dividends | -97.7% | -11.7% | -87.4% | +48.6% | +106.4% |
| 5-Year ReturnCumulative with dividends | -97.7% | -12.5% | -93.5% | -21.1% | +286.9% |
| 10-Year ReturnCumulative with dividends | -97.7% | +5.3% | -86.2% | -26.8% | +348.1% |
| CAGR (3Y)Annualised 3-year return | -71.5% | -4.0% | -49.9% | +14.1% | +27.3% |
Risk & Volatility
Evenly matched — HCSG and MCK each lead in 1 of 2 comparable metrics.
Risk & Volatility
MCK is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than OMI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HCSG currently trades 91.5% from its 52-week high vs WGRX's 1.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.96x | 0.73x | 1.44x | 1.12x | 0.04x |
| 52-Week HighHighest price in past year | $7.04 | $89.29 | $9.55 | $24.39 | $999.00 |
| 52-Week LowLowest price in past year | $0.08 | $61.95 | $1.84 | $12.66 | $637.00 |
| % of 52W HighCurrent price vs 52-week peak | +1.3% | +79.0% | +23.5% | +91.5% | +75.3% |
| RSI (14)Momentum oscillator 0–100 | 31.2 | 39.1 | 46.5 | 61.8 | 16.2 |
| Avg Volume (50D)Average daily shares traded | 13.8M | 1.2M | 690K | 676K | 757K |
Analyst Outlook
HCSG leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: HSIC as "Hold", OMI as "Hold", HCSG as "Hold", MCK as "Buy". Consensus price targets imply 78.6% upside for OMI (target: $4) vs 9.8% for HCSG (target: $25). MCK is the only dividend payer here at 0.36% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $86.43 | $4.00 | $24.50 | $1006.50 |
| # AnalystsCovering analysts | — | 32 | 10 | 15 | 31 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.4% |
| Dividend StreakConsecutive years of raises | — | 1 | 0 | 20 | 17 |
| Dividend / ShareAnnual DPS | — | — | — | — | $2.69 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +10.5% | 0.0% | +3.9% | +3.4% |
HCSG leads in 2 of 6 categories (Profitability & Efficiency, Analyst Outlook). HSIC leads in 1 (Income & Cash Flow). 1 tied.
WGRX vs HSIC vs OMI vs HCSG vs MCK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is WGRX or HSIC or OMI or HCSG or MCK a better buy right now?
For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.
2% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 6x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate McKesson Corporation (MCK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — WGRX or HSIC or OMI or HCSG or MCK?
On trailing P/E, Henry Schein, Inc.
(HSIC) is the cheapest at 21. 6x versus McKesson Corporation at 29. 2x. On forward P/E, Owens & Minor, Inc. is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: McKesson Corporation wins at 0. 49x versus Henry Schein, Inc. 's 4. 21x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — WGRX or HSIC or OMI or HCSG or MCK?
Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +286.
9%, compared to -97. 7% for Wellgistics Health, Inc. (WGRX). Over 10 years, the gap is even starker: MCK returned +348. 1% versus WGRX's -97. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — WGRX or HSIC or OMI or HCSG or MCK?
By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at 0.
04β versus Owens & Minor, Inc. 's 1. 44β — meaning OMI is approximately 3251% more volatile than MCK relative to the S&P 500. On balance sheet safety, Healthcare Services Group, Inc. (HCSG) carries a lower debt/equity ratio of 5% versus 4% for Wellgistics Health, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — WGRX or HSIC or OMI or HCSG or MCK?
By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.
2% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: Healthcare Services Group, Inc. grew EPS 52. 8% year-over-year, compared to -201. 1% for Owens & Minor, Inc.. Over a 3-year CAGR, MCK leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — WGRX or HSIC or OMI or HCSG or MCK?
Healthcare Services Group, Inc.
(HCSG) is the more profitable company, earning 3. 2% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 3. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HSIC leads at 5. 7% versus -33. 9% for WGRX. At the gross margin level — before operating expenses — HSIC leads at 29. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is WGRX or HSIC or OMI or HCSG or MCK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, McKesson Corporation (MCK) is the more undervalued stock at a PEG of 0. 49x versus Henry Schein, Inc. 's 4. 21x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Owens & Minor, Inc. (OMI) trades at 2. 3x forward P/E versus 20. 8x for Healthcare Services Group, Inc. — 18. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 78. 6% to $4. 00.
08Which pays a better dividend — WGRX or HSIC or OMI or HCSG or MCK?
In this comparison, MCK (0.
4% yield) pays a dividend. WGRX, HSIC, OMI, HCSG do not pay a meaningful dividend and should not be held primarily for income.
09Is WGRX or HSIC or OMI or HCSG or MCK better for a retirement portfolio?
For long-horizon retirement investors, McKesson Corporation (MCK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
04), +348. 1% 10Y return). Both have compounded well over 10 years (MCK: +348. 1%, OMI: -86. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between WGRX and HSIC and OMI and HCSG and MCK?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: WGRX is a small-cap quality compounder stock; HSIC is a small-cap quality compounder stock; OMI is a small-cap quality compounder stock; HCSG is a small-cap quality compounder stock; MCK is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.